The tilapia aquaculture vaccines market is anticipated to cross USD 45.5 million in global remuneration by 2025. There is a prominent demand for tilapia fish species in the international landscape owing to its economic importance. The Food and Agriculture Organization of the United Nations (FAO) had stated that the tilapia in the year 2015 accounted for 7.4% of the total aquaculture production and can be regarded as the second most vital of all the finfish species across the globe. Besides, the production of tilapia involves easy cultural techniques and short time duration.

Aquaculture vaccines offer superior protection against contagions and do not project any adverse effects related to antibodies like resistance and disease recurrence. Prevailing instances of viral and bacterial infections across the globe will drive the aquaculture vaccines market forecast in the coming years. There is also a higher preference for vaccinations in comparison to antibiotics to counter these ailments.

Get sample copy of this research report @

Fish like salmon are known to provide vital nutrients to humans, including proteins, vitamins, minerals antioxidants and more importantly Omega-3 fatty acids, which are considered helpful in maintaining a heathy heart. Owing to these benefits, intake of different fish species and products have only increased with the rise in population. The UN Food and Agriculture Organization states that in 2016, fish production had reached around 171 million tons worldwide, where aquaculture contributed nearly 47% of the total production. This contribution is predicted to increase every year since capture fishery production has become stagnant, promising highly lucrative prospects for the aquaculture vaccines market to help ensure the health and safety of seafood consumed.  

Speaking on regional opportunities, North America represents a key target base for aquaculture vaccine manufacturers and developers, due to constantly surging fish consumption and the presence of thousands of fish farms and canned food producers. Salmon has become a significant part of American diet and the region witnesses a wide variety of this species being farmed across the continent. Canada is a nation which not only consumes a vast amount of fish products but also exports them. As such, producers have to supply healthy fish meant for frozen food and processing plants, or they can risk the health of domestic as well as global customers. The aquaculture vaccines market could gain remarkable momentum in the country, as implied by the fact that Canada’s seafood preparation and packaging sector was valued at approx. US$4 billion in 2017.

Increased concerns regarding possible outbreak of fish diseases has kept the regional and international health organizations on alert. In 2018, the Canadian Food Inspection Agency had discovered the occurrence of infectious salmon anemia (ISA) at a fish farm in the eastern parts of the country. The viral outbreak was allegedly the fifth such reporting in the province of Newfoundland and Labrador in the year and eighth in Canada. In addition, the aquaculture vaccines market is continuously garnering revenues from seafood companies to prevent any outbreaks of bacterial infections, which are the most common diseases affecting fish farming.

Request for a Customization of this research report @

Hipra, Zoetis Inc., Tecnovax, Veterquimica S.A., Virbac, and Nisseiken Co. Ltd are some of the other global brands in the business.

Partial Chapter of the Table of Content

Chapter 4.    Aquaculture Vaccines Market, By Type of Vaccines

4.1. Key segment trends

4.2. Inactivated vaccines

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3. Live vaccines

4.3.1. Market size, by region, 2014 – 2025  (USD Million)

4.4. Others

4.4.1. Market size, by region, 2014 – 2025  (USD Million)

Chapter 5.    Aquaculture Vaccines Market, By Route of Administration

5.1. Key segment trends

5.2. Immersion vaccines

5.2.1.  Market size, by region, 2014 – 2025 (USD Million)

5.3. Injection vaccines

5.3.1.  Market size, by region, 2014 – 2025 (USD Million)

5.4. Oral vaccines

5.4.1.  Market size, by region, 2014 – 2025 (USD Million)

Chapter 6.    Aquaculture Vaccines Market, By Application

6.1.  Key segment trends

6.2.  Bacterial infection

6.2.1.    Market size, by region, 2014 – 2025 (USD Million)

6.3.  Viral infection

6.3.1.    Market size, by region, 2014 – 2025 (USD Million)

6.4.  Others

6.4.1.    Market size, by region, 2014 – 2025  (USD Million)

Browse complete Table of Contents (ToC) of this research report @